These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9293971)

  • 1. The kallikrein-kinin system in post-myocardial infarction cardiac remodeling.
    Wollert KC; Drexler H
    Am J Cardiol; 1997 Aug; 80(3A):158A-161A. PubMed ID: 9293971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
    Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
    Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinin B1 receptor blockade and ACE inhibition attenuate cardiac postinfarction remodeling and heart failure in rats.
    Lin X; Bernloehr C; Hildebrandt T; Stadler FJ; Doods H; Wu D
    Toxicol Appl Pharmacol; 2016 Aug; 305():153-160. PubMed ID: 27288733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction.
    Yao YY; Yin H; Shen B; Chao L; Chao J
    J Card Fail; 2007 Sep; 13(7):588-96. PubMed ID: 17826650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
    Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
    Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size.
    Linz W; Wiemer G; Schölkens BA
    Am J Cardiol; 1997 Aug; 80(3A):118A-123A. PubMed ID: 9293964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
    Zhu YC; Zhu YZ; Gohlke P; Stauss HM; Unger T
    Am J Cardiol; 1997 Aug; 80(3A):110A-117A. PubMed ID: 9293963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
    Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H; Miatello R; Damiani MT; Abate CD
    Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin (B2) independent effect of captopril on the development of pressure overload cardiac hypertrophy.
    Turcani M; Rupp H
    Mol Cell Biochem; 2000 Sep; 212(1-2):219-25. PubMed ID: 11108154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
    Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA
    Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction.
    Blais C; Lapointe N; Rouleau JL; Clément R; Gervais N; Geadah D; Adam A
    Peptides; 2001 Jun; 22(6):953-62. PubMed ID: 11390026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expression.
    Blais C; Lapointe N; Rouleau JL; Clément R; Bachvarov DR; Adam A
    Can J Physiol Pharmacol; 2002 Jan; 80(1):48-58. PubMed ID: 11911226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kallikrein-kinin system as a regulator of cardiovascular and renal function.
    Rhaleb NE; Yang XP; Carretero OA
    Compr Physiol; 2011 Apr; 1(2):971-93. PubMed ID: 23737209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.